The Pathogenetic Mechanism for Moyamoya Vasculopathy Including a Possible Trigger Effect of Increased Flow Velocity
- PMID: 36793526
- PMCID: PMC9908406
- DOI: 10.31662/jmaj.2022-0104
The Pathogenetic Mechanism for Moyamoya Vasculopathy Including a Possible Trigger Effect of Increased Flow Velocity
Abstract
Moyamoya disease (MMD), which commonly exhibits moyamoya vasculopathy characterized by chronic progressive steno-occlusive lesions in the circle of Willis with "moyamoya" collateral vessels, has been well known for its unique demographic and clinical features. Although the discovery of the susceptibility gene RNF213 for MMD revealed the factor for its predominance in East Asians, the mechanisms underlying other predominant conditions (females, children, young to middle-aged adults, and anterior circulation) and lesion formation are yet to be determined. As MMD and moyamoya syndrome (MMS), which secondarily produces moyamoya vasculopathy due to pre-existing diseases, have the same vascular lesions despite differences in their original pathogenesis, they may share a common trigger for the development of vascular lesions. Thus, we herein consider a common trigger from a novel perspective on blood flow dynamics. Increased flow velocity in the middle cerebral arteries is an established predictor of stroke in sickle cell disease, which is often complicated by MMS. Flow velocity is also increased in other diseases complicated by MMS (Down syndrome, Graves' disease, irradiation, and meningitis). In addition, increased flow velocity occurs under the predominant conditions of MMD (females, children, young to middle-aged adults, and anterior circulation), suggesting a relationship between flow velocity and susceptibility to moyamoya vasculopathy. Increased flow velocity has also been detected in the non-stenotic intracranial arteries of MMD patients. In a pathogenetic overview of chronic progressive steno-occlusive lesions, a novel perspective including the trigger effect of increased flow velocity may provide insights into the mechanisms underlying their predominant conditions and lesion formation.
Keywords: Increased flow velocity; Moyamoya disease; Moyamoya syndrome; Moyamoya vasculopathy; Pathogenetic mechanism.
Copyright © Japan Medical Association.
Conflict of interest statement
None
Figures


Similar articles
-
Moyamoya vasculopathy shows a genetic mutational gradient decreasing from East to West.J Neurosurg Sci. 2020 Apr;64(2):165-172. doi: 10.23736/S0390-5616.16.03900-X. Epub 2016 Oct 27. J Neurosurg Sci. 2020. PMID: 27787485
-
Moyamoya Vasculopathy in Neurofibromatosis Type 1 Pediatric Patients: The Role of Rare Variants of RNF213.Cancers (Basel). 2023 Mar 22;15(6):1916. doi: 10.3390/cancers15061916. Cancers (Basel). 2023. PMID: 36980803 Free PMC article.
-
Moyamoya Disease and Spectrums of RNF213 Vasculopathy.Transl Stroke Res. 2020 Aug;11(4):580-589. doi: 10.1007/s12975-019-00743-6. Epub 2019 Oct 24. Transl Stroke Res. 2020. PMID: 31650369 Review.
-
Early manifestation of Moyamoya syndrome in a 2-year-old child with Down syndrome.Radiol Case Rep. 2021 May 1;16(7):1740-1744. doi: 10.1016/j.radcr.2021.04.017. eCollection 2021 Jul. Radiol Case Rep. 2021. PMID: 34007395 Free PMC article.
-
Imaging of Moyamoya Disease and Moyamoya Syndrome: Current Status.J Comput Assist Tomogr. 2019 Mar/Apr;43(2):257-263. doi: 10.1097/RCT.0000000000000834. J Comput Assist Tomogr. 2019. PMID: 30589721 Free PMC article. Review.
Cited by
-
Achieving robust labeling above the circle of Willis with vessel-encoded arterial spin labeling.Magn Reson Med. 2025 Oct;94(4):1415-1431. doi: 10.1002/mrm.30542. Epub 2025 Jul 1. Magn Reson Med. 2025. PMID: 40590250 Free PMC article.
-
Moyamoya Disease and Flow Velocity.JMA J. 2023 Jan 16;6(1):25-26. doi: 10.31662/jmaj.2022-0191. Epub 2022 Dec 26. JMA J. 2023. PMID: 36793529 Free PMC article. No abstract available.
-
The role of obstructive sleep apnea/hypopnea for leukoaraiosis and its cognitive consequences: a discussion still open!Sleep. 2025 Feb 10;48(2):zsae283. doi: 10.1093/sleep/zsae283. Sleep. 2025. PMID: 39656770 Free PMC article. No abstract available.
References
-
- Kuroda S, Houkin K. Moyamoya disease: current concepts and future perspectives. Lancet Neurol. 2008;7(11):1056-66. - PubMed
-
- Scott RM, Smith ER. Moyamoya disease and moyamoya syndrome. N Engl J Med. 2009;360(12):1226-37. - PubMed
-
- Houkin K, Ito M, Sugiyama T, et al. Review of past research and current concepts on the etiology of moyamoya disease. Neurol Med Chir (Tokyo). 2012;52(5):267-77. - PubMed
-
- Fujimura M, Bang OY, Kim JS. Moyamoya disease. Front Neurol Neurosci. 2016;40:204-20. - PubMed
-
- Kuriyama S, Kusaka Y, Fujimura M, et al. Prevalence and clinicoepidemiological features of moyamoya disease in Japan: findings from a nationwide epidemiological survey. Stroke. 2008;39(1):42-7. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Research Materials